Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinmaikang Capsule for Stable Angina (Qi Stagnation, Blood Stasis, Phlegm Obstruction)
CTR20140221Phase 3Active
- Sponsor
- First Affiliated Hospital of Guangxi University of Chinese Medicine
- Start
- Apr 2014
- Countries
- 1
01
Overview
A Phase 3 trial of Xinmaikang in coronary arteriosclerosis, stable angina, sponsored by First Affiliated Hospital of Guangxi University of Chinese Medicine. Started Apr 2014; status: active.
02
Drugs
Xinmaikang
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on CTR20140221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140221.